Filter posts

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

BIO 2014’s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move …

Alzheimer’s Association offers Research Grant Program

The Alzheimer’s Association offers the Part the Cloud Translational Research Grant Program, which aims to …

A Manhattan Project for Alzheimer's Disease

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & …

Unraveling the Mystery of Alzheimer’s Disease

Preeminent researchers from around the world gathered recently to tackle the science behind one of …

Alzheimer’s Disease “Robs You of Everything”

George Hendrick and his wife, Mary Lee, experienced the typical highs and lows of parenthood …

Q & A with Eli Lilly’s Eric Siemers

In October 2012, Eli Lilly and Company released results of its Expedition trials, two Phase …

Approving Drugs for Alzheimer’s Disease

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory …

BIO Technology Transfer Symposium: Funding that First $2 Million

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, …

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s …

“The Ultimate Pig”

The 7th Transgenic Animal Conference held this week in Tahoe, Calif. came to a close …